Cas:893740-46-0 5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid manufacturer & supplier

We serve Chemical Name:5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid CAS:893740-46-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid

Chemical Name:5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid
CAS.NO:893740-46-0
Synonyms:5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid
Molecular Formula:C13H8F3NO2
Molecular Weight:267.20300
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:50.19000
Exact Mass:267.05100
LogP:3.46560

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid Use and application,5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid technical grade,usp/ep/jp grade.


Related News: The group of diseases known as severe combined immunodeficiency, or SCID, first drew wide attention decades ago because of David Vetter, a boy born with X-linked SCID who lived in a bubble for 12 years as doctors tried to figure out how to cure him. dimethyl-(5-methyl-7-propyl-imidazo[1,5-b]pyridazin-2-yl)-amine manufacturers Grégoire holds a Masters’ degree in Fundamental Physics from Pierre and Marie Curie University. 2-chloro-N-(2-chloroethyl)-N-di(imidazol-1-yl)phosphorylethanamine suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. [4-[3-(2-chloroethylsulfanyl)propanoylamino]phenyl]phosphonic acid vendor & factory.